Instructor, Lowance Center for Human Immunology, Emory University
I received a BS in biotechnology in 2008 from the Rochester Institute of Technology (RIT). Immediately following, I attended Harvard University as a doctoral candidate in immunology, graduating in 2014 with a thesis describing the earliest phases of immune response following influenza vaccination. In 2014 I pursued a postodoctoral fellowship at Emory University, again studying the early phases of immune response (specifically antibody selection). I published that work in 2018, and transitioned into a human immunology lab under Dr. Iñaki Sanz, specializing in the study of autoimmune diseases. Since the start of the COVID-19 pandemic, I have refocused almost entirely on studying the immune responses in patients with severe COVID-19. I am a member of the Scholars Strategy Network, and have a strong interest in public outreach.
Oct 09, 2020 07:01 am UTC| Health
In the earliest days of the pandemic, many immunologists, including me, assumed that patients who produced high quantities of antibodies early in infection would be free from disease. We were wrong. Several months into...